Solutions
Digital Cognitive Assessment
Endpoint Data Quality (Rater Services)
Remote Assessment
Scientific Consulting
Healthcare Cognitive Screening
Research and Academic Collaborations
Therapeutic Expertise
Alzheimer’s Disease and Dementia
Preclinical Alzheimer’s Disease
Pediatrics & Rare Disease
Parkinson’s Disease
Multiple Sclerosis
Schizophrenia
Oncology
Safety
Resources
Fact Sheets
Webinars
Posters
Publications
Blog
Company
About Cogstate
Leadership Teams
Clinical & Scientific Network (LEADs)
Company News
Careers & Life at Cogstate
CTAD 2023
Investor Centre
Corporate Governance
Board of Directors
ASX Announcements & Share Price
Financial Reports
Investor Presentations
Financial Calendar
Shareholder Information
Contact Us
Support
Solutions
Digital Cognitive Assessment
Endpoint Data Quality (Rater Services)
Remote Assessment
Scientific Consulting
Healthcare Cognitive Screening
Research and Academic Collaborations
Therapeutic Expertise
Alzheimer’s Disease and Dementia
Preclinical Alzheimer’s Disease
Pediatrics & Rare Disease
Parkinson’s Disease
Multiple Sclerosis
Schizophrenia
Oncology
Safety
Resources
Fact Sheets
Webinars
Posters
Publications
Blog
Company
About Cogstate
Leadership Teams
Clinical & Scientific Network (LEADs)
Company News
Careers & Life at Cogstate
CTAD 2023
Investor Centre
Corporate Governance
Board of Directors
ASX Announcements & Share Price
Financial Reports
Investor Presentations
Financial Calendar
Shareholder Information
Contact Us
Support
Latest News
Find updates from Cogstate, leaders in the measurement of cognition.
Search
Show All
April 5, 2018
Cogstate Establishes Rare Disease and Pediatric Center of Excellence
June 27, 2017
Pilot Study Demonstrates Working Memory Training May Be Effective For Children With Neurofibromatosis
May 12, 2017
Cogstate Brief Battery Effective For Detecting Cognitive Impairment in Pediatric MS Patients
